ChannelAdvisor IPO ...
Technology: Electronics
Bio-Rad Laboratories Inc. (BIO: NYSE)
$115.57 0.18 | 0.16%
05/23/13 - 04:00 PM ET
66.47K / 89.20K
Vol / Avg. Vol:114.93 / 115.39
Open / Prev. Close:113.53 - 116.56
Today's Range:91.52 - 127.17
52 Wk Range:9.84%
Performance YTD:TheStreet Rating:
Portfolios with BIO
- Portfolio NameUser Type
- Usertutorperth's bio
- ContributorTop-Rated Life Sciences Stocks
- Contributor8 Health Care Stocks to Buy
- UserMontana Nugget
- ProJohn Rogers - Ariel Capital...
- UserTom's Dream
- UserPART 1 JPMorgan 27th Annual...
- UserRAPTOR SPRTD RED-0811082015
- UserBaby Boomers Part II
- UserTop AmEx Short Squeeze Stoc...
Latest BIO Headlines from TheStreet
- Bio-Rad Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 04:08 am
- Bio-Rad Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 10:05 pm
- Bio-Rad Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.23.12 | 11:02 pm
- Bio-Rad Laboratories' CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.01.11 | 06:11 pm
- 8 Health Care Stocks to Buy 10.13.11 | 11:10 am
- 10 Health Care Stocks to Watch 08.04.11 | 01:08 pm
- Bio-Rad Laboratories' CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.02.11 | 10:08 pm
- Bio-Rad Stock Hits New 52-Week High (BIO) 04.29.11 | 12:04 pm
- Harvard Biosciences CEO: Growing Organs - Growing Sales
04.24.11 | 06:04 am - HCA, Eaton, Cabot: Analysts' New Ratings 04.19.11 | 09:04 am
Press Releases for BIO
- Bio-Rad Receives The 2012 Frost & Sullivan North America Laboratory Researchers' Choice Award For Future Market Leader - PR Newswire 03.12.13 | 07:03 am
- Biotest Pharmaceuticals Announces Strategic Long-Term Manufacturing, Supply And License Agreement - PR Newswire 01.10.13 | 04:01 pm
- BioAlliance Pharma SA: Initiation Of ReLive, Phase III Clinical Trial With Livatag® In Primary Liver Cancer - Business Wire 05.14.12 | 12:05 pm
- New Actavis / Bioton Alliance To Shake Up Diabetes Market - PR Newswire 01.30.12 | 06:01 am
- Biosign And EasyMed Sign LOI To Collaborate On Mobile Health Offering - PR Newswire 12.05.11 | 10:12 am
- Biosign Technologies Retains IR Firm Bay Street Connect And Grant Of Stock Options - PR Newswire 11.14.11 | 07:11 am
- Biosign's Health Monitor System Will Be Shown At MEDICA 2011 - PR Newswire 11.11.11 | 07:11 am
- Biosign Develops Algorithm For Use In Pre-Screening For Arrhythmia - PR Newswire 11.10.11 | 10:11 am
- Biosign Corporate Update - PR Newswire 11.03.11 | 01:11 pm
- BioAlliance Pharma Announces 2 Key Decisions - Business Wire 09.07.11 | 12:09 pm
Partner Headlines for BIO
- Bio-Rad Labs Earnings: Here’s Why Investors Like These Results - Wall St. Cheat Sheet 05.07.13 | 06:05 am
- Covance Inc. (CVD): Today's Most Compelling Stock Buy - NASDAQ 05.06.13 | 03:05 pm
- After-Hours Earnings Report for February 26, 2013 : PCLN, VNO, EIX, RRC, WFT, VRSK, AVGO, AWK, ERIE, JAZZ, FSLR, BIO - NASDAQ 02.26.13 | 07:02 pm
- Bio-Rad's New Digital Biology Center - Analyst Blog - NASDAQ 08.30.12 | 09:08 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 04.19.12 | 09:04 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 04.16.12 | 09:04 am
- Seracare Undervalued, Under The Radar, And Eager To Be Acquired - Seeking Alpha 02.14.12 | 09:02 am
- Top Stock Picks From John Rogers - Seeking Alpha 12.01.11 | 08:12 am
- HONDA MOTOR (HMC) - Profit Tracks - Zacks 10.21.11 | 01:10 am
- John Rogers' Contrarian Bets Beat Most Hedge Funds in 2010 - Seeking Alpha 03.12.11 | 09:03 am
